These Are The Top Marijuana Stocks Investors Should Follow2026 could be a big year for marijuana stocks and even bigger for the industry as a whole. By now, most are aware of the rescheduling of cannabis carried out by Donald Trump. From an industry stance, this will change many things, hopefully for the better. That is the thought, anyway, especially with various other measures soon to be voted on. News on reform often triggers a bounce for most cannabis stocks. In fact, finding top cannabis stocks to buy ...

Industry Overview - The marijuana sector is currently trading at low share prices, but upcoming reforms and rescheduling may lead to a rebound in stock prices [1][2] - The cannabis market is experiencing growth not only in the US but also in Canada and Europe, with Canada being the first country to fully legalize cannabis [1] Regulatory Changes - The US has reclassified cannabis as a Schedule 3 substance, which may facilitate collaboration with foreign markets and improve the public sector's growth prospects [2] - There is a call for legislative alignment with the new cannabis rescheduling to support safe banking reforms, which would enhance financial transaction security in the cannabis industry [5] Company Highlights - **Planet 13 Holdings Inc.** focuses on cultivating and providing cannabis products for medical and retail markets in the US and supports the new cannabis bill introduced by Trump [4][10] - **FLUENT Corp.** has sold its Pennsylvania operations for US$12.5 million, aiming to strengthen its balance sheet and focus on markets with greater opportunities [7][8] - **Glass House Brands Inc.** operates in retail, wholesale biomass, and cannabis-related consumer packaged goods, and supports the rescheduling of cannabis, viewing it as a significant drug reform [10]

Our Brandon Gomez has more on why that move came about and why now. Hey Brandon, >> instead investors clearly seeing more haze ahead. Still, the group holding solid gains monthto date.Let's start with what actually happened yesterday. President Trump signed an executive order directing the DEA to reclassify cannabis from schedule 1 to schedule 3. Now that eases restrictions on medical research, banking, and taxes.The administration also launched a Medicare pilot program allowing some seniors starting in Apr ...

LONG BEACH, Calif. and TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest-growing, vertically-integrated cannabis companies in the U.S., applauds yesterday’s cannabis reform action from the Trump administration. “The executive order to reschedule cannabis to a Schedule III classification and the authorization of a pilot program for Medicare reimbursement of the cannabis ...

The Company confirms it is assessing U.S. licensing pathways for its Canna Cabana retail brand NuLeaf Naturals and FAB CBD evaluating Medicare-aligned product categories CALGARY, AB, Dec. 18, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, today welcomed the Executive Order issued by the White House advancing the rescheduling of cannabis ...

Reclassification Eases Barriers to Research and Removes Punitive 280E Tax Burden  TALLAHASSEE, Fla., Dec. 18, 2025 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., applauds action taken by the Trump Administration to reclassify marijuana to Schedule III under the Controlled Substances Act. "This bold and historic direction from President Trump represents long overdue change and a major milestone in ...

NORWOOD, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator committed to improving lives every day, issued the following statement from CEO Jon Levine today. “We commend President Trump and the Trump Administration for reclassifying cannabis as a Schedule III drug. This is the single greatest cannabis reform in US history and will have far-reaching benefits for years to come. Most important, the reclassification means the Fede ...

Top Marijuana Stocks That Can Make You Money In 2026Much of the talk surrounding marijuana stocks trading better is based on new reform. Right now, many are waiting to see what Donald Trump will do regarding making cannabis a Class 3 substance. This news has set the cannabis sector ablaze. Right now, people are focusing on how to take advantage of this and make a profit. With a new year around the corner, using speculation on reform measures is a strategy some will take towards making a profit.Often, when n ...

Core Insights - The U.S. cannabis industry is nearing a significant inflection point, with ongoing federal policy discussions, particularly regarding cannabis rescheduling, which could lead to reduced tax burdens and improved profitability for operators [1][2] - Recent state-level expansions of adult-use programs and medical access frameworks, along with renewed federal banking reform discussions, are contributing to a growing momentum for legalization [2][6] - Companies with strong balance sheets and retail scale, such as Trulieve, Green Thumb Industries, and Cresco Labs, are well-positioned for growth as federal reforms progress [5][6] Industry Overview - The U.S. cannabis industry is evolving amidst regulatory uncertainty, with large multi-state operators focusing on long-term growth through scale, efficiency, and strong balance sheets [6][20] - Federal reform may be gradual, but even incremental changes could unlock significant value for cannabis companies [5][20] Company Profiles Trulieve Cannabis Corp. - Trulieve is one of the largest U.S. cannabis operators, with over 180 dispensaries, primarily in Florida, and a strong market share [9][10] - The company emphasizes cash flow stability, with steady revenue and strong gross margins, while maintaining disciplined capital expenditures and avoiding excessive dilution [12][10] Green Thumb Industries Inc. - Green Thumb operates over 100 dispensaries and focuses on branded consumer products, which differentiates it from competitors [13][14] - The company has maintained positive net income and strong operating cash flow, with a conservative balance sheet and manageable debt levels [15][14] Cresco Labs Inc. - Cresco is a vertically integrated operator with a strong wholesale focus, operating retail locations under the Sunnyside brand and maintaining a presence in key states [16][17] - The company has focused on stabilization and efficiency, with steady revenue and improving gross margins, while managing operating expenses carefully [19][18]

Core Insights - Marijuana stocks are experiencing increased trading activity and optimism due to potential reform measures expected in 2026, including home grow legislation in Florida and possible executive actions from Donald Trump to reschedule cannabis [1][2][3] Industry Overview - The anticipation of reform is boosting investor sentiment, with speculation driving the potential for stock price increases in the cannabis sector [2] - Several bills are set to be voted on in 2026, which could significantly impact the performance of leading cannabis stocks [2] Company Highlights - **Ascend Wellness Holdings, Inc.**: Engages in the cultivation, manufacture, and distribution of cannabis products. Recently announced a partnership with Mister Jones in New Jersey, marking a significant milestone under new state regulations [4][6] - **Ayr Wellness Inc.**: Involved in the cultivation and retail of cannabis products. The company is undergoing restructuring under the Companies' Creditors Arrangement Act, transitioning core assets to a new acquisition vehicle owned by senior noteholders [7][9] - **Trulieve Cannabis Corp.**: Operates as a cannabis retailer, cultivating and distributing cannabis products. Recently announced a private placement of 10.5% Senior Secured Notes due 2030, raising US$100 million [9][11]